Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Daily Feed
  • Analyst Insights & IR
  • Disclosures
    • Semiconductors
    • Energy
    • Robotics
    • Bio & Healthcare
  • Toggle search form

[Disclosure] Alteogen (196170) Designated as Short-Selling Overheated Stock; Short-Selling Banned on May 15

Posted on May 14, 2025July 11, 2026 By K-STOCK Editor No Comments on [Disclosure] Alteogen (196170) Designated as Short-Selling Overheated Stock; Short-Selling Banned on May 15

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-05-14

Disclosure Type: Designation as Short-Selling Overheated Stock (Short-Selling Trading Ban Applied)

💡 3-Second Summary

Alteogen has been designated as a “Short-Selling Overheated Stock” by the Korea Exchange due to a sharp surge in short-selling volume. Consequently, short-selling activities in both regular and after-hours markets will be strictly prohibited for one day on May 15, 2025.

📊 1. [Summary of Core Disclosure Content and Key Figures]

  • Target Stock: Alteogen (Ticker 196170)
  • Designation Date (Ban Period): May 15, 2025 (Applicable for 1 trading day)
  • Market Action Details: Short-selling trading is prohibited in the regular and after-hours markets on the designation date. Trading will resume under normal short-selling rules from the day after the designation date (May 16).
  • Extension Condition: If the stock price drops by -5% or more on the day short-selling is banned, the short-selling restriction period will be further extended.
  • Permitted Exceptions: Short-selling is exceptionally allowed for liquidity provision quotes (LP), market-making quotes, hedge trading aimed at providing liquidity for ELW, ETF, and ETN products, and market-making hedge quotes in derivatives markets.
  • Special Case: If trading of the designated stock is already suspended on the designation date, no separate actions under this disclosure will be enforced.

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This disclosure serves as an administrative marker indicating that short-selling trades targeting Alteogen have recently escalated to abnormal levels. It is a regulatory market action enforced under KOSDAQ market operational provisions, rather than an event reflecting a shift in corporate Fundamental, such as biotechnology pipeline developments or revenue revisions.

For investors, the primary metric to follow is the temporary easing of short-side supply pressures, as short-selling is blocked on the target date except for designated hedging transactions. This restriction may exert a positive potential impact by temporarily dampening short-term downward technical pressure. However, because it is a single-day administrative intervention and short-selling can resume on the following day, investors should remain objective and observe intraday price volatility to see if the -5% threshold is tested, which would trigger an extension of the ban.

📝 Editor’s Comment (by K-STOCK Editor)

The Korea Exchange has pulled the emergency brake on short-sellers as speculative volume hit the red zone for Alteogen! For one full session on Thursday, May 15, short-selling avenues will be tightly locked down. Excluding standard corporate market-making exceptions, all eyes will be on whether this catalyst sparks brief short-covering support or just a minor breathing room for the stock. Don’t forget the built-in rule: if the stock slips past -5% on the ban day, the short-selling lock gets extended. Keep your terminals open and monitor the bidding blocks closely!

📢 Disclaimer and Source Information

Source: This content has been newly structured and written based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This content is provided solely for information and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] HANMI Semiconductor (042700) Terminates 40B KRW Treasury Share Trust: Acquired 470K Shares Set for ‘Complete Cancellation in May’
Next Post: [Disclosure] Hana Micron (067310) Unveils Bold ‘Corporate Value-Up Plan’; Targeting KRW 3.2T Revenue & Global OSAT Top 5 by 2030 Aligned with Aggressive Capital Returns

Related Posts

[Disclosure] Alteogen (196170) Transferred from Technology Growth Business Division to Blue-Chip Business Division Disclosures
[Disclosure] Alteogen(196170) Approves Delisting from KOSDAQ and Relisting on KOSPI at Extraordinary Shareholders’ Meeting Disclosures
Alteogen(196170) to Host Large-Scale Overseas IR in Hong Kong and Singapore, Unveiling R&D Pipelines to Global Institutional Investors Disclosures
[Disclosure] Alteogen (196170) Reports Q1 2026 Operating Profit of KRW 39.3B… An Explosive 100% QoQ Surge Disclosures
[Disclosure] Alteogen (196170) to Hold AGM on March 31; Agenda Includes Re-appointment of CEO Park Soon-jae and Appointment of VP Choi Sang-rak as Inside Director Disclosures
[Disclosure] Alteogen (196170) Scores Huge Win: Eylea Biosimilar ‘Eyzanfy’ Secures Official MFDS Marketing Approval in South Korea Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hana Micron (067310) Lifted from Investment Warning Stock Status; Reclassified to Investment Caution on June 9 with Re-designation WarningJuly 8, 2026
  • [Discount Reversal via ADR Listing and Entry into an HBM-Led Super Cycle: SK hynix 000660]July 7, 2026
  • [Discount Narrowing via ADR Listing Momentum and Capital Allocation Diversification: SK Square 402340]July 7, 2026
  • Gaon Cable (000500): Structural Re-rating Driven by North American Infrastructure Expansion and AI Data Center Demand ShocksJuly 7, 2026
  • Hugel (145020): Passing the Trough with Q2 Earnings Surprise and Accelerated U.S. Direct Sales DeploymentJuly 7, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme